Related Experiment Video
Updated: Dec 3, 2025

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
Evolving Trends in Adult Heart Transplant With the 2018 Heart Allocation Policy Change
Arman Kilic1, Michael A Mathier2, Gavin W Hickey2
1Division of Cardiac Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Insights
The US heart transplant policy change in 2018 improved waitlist outcomes but decreased post-transplant survival. Continued evaluation of the new heart allocation policy is crucial.
Area of Science:
- Cardiology
- Transplantation Medicine
- Health Policy
Background:
- The US heart allocation policy was revised on October 18, 2018.
- The impact of this policy change on recipient and donor selection and outcomes requires thorough investigation.
Purpose of the Study:
- To assess changes in patient characteristics, waitlist outcomes, and post-transplant outcomes following the recent heart transplant allocation policy revision.
- To evaluate the association between the policy change and heart transplant outcomes.
Main Methods:
- A cohort study reviewed 15,631 adult heart transplants in the US from a national registry.
- Patients were stratified into pre-policy change (Oct 1, 2015 - Oct 1, 2018) and post-policy change (Oct 18, 2018 onwards) groups.
- Competing risk regression and multivariable Cox proportional hazards regression were used to analyze outcomes.
Main Results:
- Post-policy change, waitlisted patients had a reduced likelihood of mortality or deterioration (SHR, 0.60) and increased likelihood of transplant (SHR, 1.38).
- However, post-transplant survival decreased after the policy change (1-year survival: 92.1% vs 87.5%, P<.001), persisting after risk adjustment (HR, 1.29).
- Changes included increased use of temporary mechanical circulatory support and decreased use of durable left ventricular assist devices for bridging.
Conclusions:
- The 2018 US heart allocation policy revision led to improved waitlist outcomes but a decline in post-transplant survival.
- These trends have persisted through 1-year follow-up, highlighting the need for ongoing reevaluation of the policy.
- The findings underscore the complex trade-offs associated with organ allocation policy changes.
Importance:
The US heart allocation policy was changed on October 18, 2018. The association of this change with recipient and donor selection and outcomes remains to be elucidated.
Objective:
To evaluate changes in patient characteristics, wait list outcomes, and posttransplant outcomes after the recent allocation policy change in heart transplant.
Design, Setting, And Participants:
In this cohort study, all 15 631 adults undergoing heart transplants, excluding multiorgan transplants, in the US as identified by the United Network for Organ Sharing multicenter, national registry were reviewed. Patients were stratified according to prepolicy change (October 1, 2015, to October 1, 2018) and postpolicy change (October 18, 2018 or after). Follow-up data were available through March 31, 2020.
Exposures:
Heart transplants after the policy change.
Main Outcomes And Measures:
Competing risk regression for wait list outcomes was performed. Posttransplant survival was compared using the Kaplan-Meier method, and risk adjustment was performed using multivariable Cox proportional hazards regression analysis.
Results:
In this cohort study, of the 15 631 patients undergoing transplant, 10 671 (mean [SD] age, 53.1 [12.7] years; 7823 [73.3%] male) were wait listed before and 4960 (mean [SD] age, 52.7 [13.0] years; 3610 [72.8%] male) were wait listed after the policy change. Competing risk regression demonstrated reduced likelihood of mortality or deterioration (subhazard ratio [SHR], 0.60; 95% CI, 0.52-0.69; P < .001), increased likelihood of transplant (SHR, 1.38; 95% CI, 1.32-1.45; P < .001), and reduced likelihood of recovery (SHR, 0.54; 95% CI, 0.40-0.73; P < .001) for wait listed patients after the policy change. A total of 6078 patients underwent transplant before and 2801 after the policy change. Notable changes after the policy change included higher frequency of bridging with temporary mechanical circulatory support and lower frequency of bridging with durable left ventricular assist devices. Posttransplant survival was reduced after the policy change (1-year: 92.1% vs 87.5%; log-rank P < .001), a finding that persisted after risk adjustment (HR, 1.29; 95% CI, 1.07-1.55; P = .008).
Conclusions And Relevance:
Substantial changes have occurred in adult heart transplant in the US after the policy change in October 2018. Wait list outcomes have improved, although posttransplant survival has decreased. These data confirm findings from earlier preliminary analyses and demonstrate that these trends have persisted to 1-year follow-up, underscoring the importance of continued reevaluation of the new heart allocation policy.
More Related Videos
06:40A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
08:15Innovative Strategies for Organ Preservation in Heart Transplantation: Uniform Cooling Preservation and Ex-situ Normothermic Perfusion
Published on: November 28, 2025
Related Concept Videos
Kidney Transplant I: Introduction
Cardiomyopathy V: Interprofessional Care
Heart Failure V: Medical Management
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...